Closing Strong: Zoetis Inc (ZTS) Ends at 155.06, Down -4.09 from Last Close

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

After finishing at $161.67 in the prior trading day, Zoetis Inc (NYSE: ZTS) closed at $155.06, down -4.09%. In other words, the price has decreased by -$4.09 from its previous closing price. On the day, 4.66 million shares were traded. ZTS stock price reached its highest trading level at $158.105 during the session, while it also had its lowest trading level at $154.54.

Ratios:

Our goal is to gain a better understanding of ZTS by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 40.11 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 30.26. For the most recent quarter (mrq), Quick Ratio is recorded 1.04 and its Current Ratio is at 1.74. In the meantime, Its Debt-to-Equity ratio is 1.45 whereas as Long-Term Debt/Eq ratio is at 1.16.

On December 02, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $215.

On July 25, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $220.BTIG Research initiated its Buy rating on July 25, 2024, with a $220 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 03 ’25 when Lagano Roxanne sold 652 shares for $170.00 per share. The transaction valued at 110,840 led to the insider holds 15,129 shares of the business.

Lagano Roxanne bought 652 shares of ZTS for $110,840 on Jun 03 ’25. On Mar 11 ’25, another insider, Reed Willie M, who serves as the Director of the company, bought 1,210 shares for $166.14 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZTS now has a Market Capitalization of 69033951232 and an Enterprise Value of 74071957504. As of this moment, Zoetis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 27.84, and their Forward P/E ratio for the next fiscal year is 22.73. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.42. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.43 while its Price-to-Book (P/B) ratio in mrq is 14.86. Its current Enterprise Value per Revenue stands at 7.977 whereas that against EBITDA is 19.155.

Stock Price History:

The Beta on a monthly basis for ZTS is 0.94, which has changed by -0.07801163 over the last 52 weeks, in comparison to a change of 0.092761636 over the same period for the S&P500. Over the past 52 weeks, ZTS has reached a high of $200.33, while it has fallen to a 52-week low of $139.70. The 50-Day Moving Average of the stock is -2.45%, while the 200-Day Moving Average is calculated to be -9.26%.

Shares Statistics:

The stock has traded on average 2.86M shares per day over the past 3-months and 2771920 shares per day over the last 10 days, according to various share statistics. A total of 446.04M shares are outstanding, with a floating share count of 444.77M. Insiders hold about 0.10% of the company’s shares, while institutions hold 95.98% stake in the company. Shares short for ZTS as of 1748563200 were 10539252 with a Short Ratio of 3.69, compared to 1745971200 on 9332612. Therefore, it implies a Short% of Shares Outstanding of 10539252 and a Short% of Float of 2.3699999.

Dividends & Splits

In the trailing 12 months, ZTS’s forward annual dividend rate was 1.796, compared to 1.86 this year. Against a Trailing Annual Dividend Yield of 0.011109049The stock’s 5-year Average Dividend Yield is 0.74.

Earnings Estimates

Current recommendations for the stock of the company come from 11.0 analysts. The consensus estimate for the next quarter is $1.65, with high estimates of $1.68 and low estimates of $1.6.

Analysts are recommending an EPS of between $6.3 and $6.14 for the fiscal current year, implying an average EPS of $6.23. EPS for the following year is $6.8, with 17.0 analysts recommending between $7.34 and $6.27.

Revenue Estimates

9 analysts predict $2.41B in revenue for the current quarter. It ranges from a high estimate of $2.44B to a low estimate of $2.35B. As of the current estimate, Zoetis Inc’s year-ago sales were $2.36BFor the next quarter, 9 analysts are estimating revenue of $2.43B. There is a high estimate of $2.46B for the next quarter, whereas the lowest estimate is $2.4B.

A total of 16 analysts have provided revenue estimates for ZTS’s current fiscal year. The highest revenue estimate was $9.54B, while the lowest revenue estimate was $9.37B, resulting in an average revenue estimate of $9.48B. In the same quarter a year ago, actual revenue was $9.26BBased on 17 analysts’ estimates, the company’s revenue will be $10.06B in the next fiscal year. The high estimate is $10.2B and the low estimate is $9.89B.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.